Dr. Bharathi Reddy is an Associate Professor of Medicine at University of Chicago. Her clinical interests are in areas of Autosomal Dominant Polycystic Kidney Disease and End Stage Renal Disease. Dr. Reddy’s academic interests focus on determining novel therapies for patients with autosomal dominant polycystic kidney disease (ADPKD). She is the principal investigator in clinical trials involving epidermal growth factor receptor antagonists, new classes of vasopressin V2 receptor antagonists. She is involved in a number of registries including the COHORT and Biomarkers studies aimed at determining novel markers of disease severity in children and adults with ADPKD.